HETERO-ATOM CONTAINING COMPOUNDS AND USES THEREOF

DUAL INHIBITOR OF HISTONE DEACETYLASE 6 AND HEAT SHOCK PROTEIN 90

FLAVONOID DERIVATIVES WITH GABAA RECEPTOR ACTIVITY AND METHODS OF USE

UTILITY OF VITAMIN D, FOLIC ACID AND NADH TO IMPROVE LIGAMENT INJURY PREVENTION CHARACTERISTICS

Compositions For and Methods of Treating and/or Preventing Pain

METHODS OF TREATING CANCER HAVING AN ACTIVE WNT/BETA-CATENIN PATHWAY

FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

Methods of Treating Lymphedema

THERAPEUTIC AGENT COMPOSITION AND METHOD OF USE, FOR TREATING, RELIEVING, OR ALLEVIATING ALZHEIMER'S DISEASE

HETEROARYL HETEROCYCLIC COMPOUNDS AND USES THEREOF

METHODS OF TREATING CANCER USING HSF1 PATHWAY INHIBITORS

FORMULATIONS OF A SOMATOSTATIN MODULATOR

HETEROARYL SUBSTITUTED BETA-HYDROXYETHYLAMINES FOR USE IN TREATING HYPERGLYCAEMIA

INHIBITORS OF THE MTDH-SND1 PROTEIN COMPLEX FOR CANCER THERAPY

ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE

Use of Chloroquine Compounds for Treatment of Inflammatory Conditions

METHOD FOR PRODUCING LIQUID MIXTURE, LIQUID MIXTURE, AND SOLID COMPOSITION

INHALABLE PROTEASE INHIBITORS FOR USE IN THE PREVENTION AND/OR TREATMENT OF FIBROTIC AUTOIMMUNE OR INFLAMMATORY LUNG DISEASES

Combination methods and compositions including sleep therapeutics for treating mood

FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE

Treating Cancers with Combinations of Spironolactone and Acylfulvenes

Diagnosis and Treatment of Vitiligo

CHOLESTOSOME VESICLES FOR INCORPORATION OF MOLECULES INTO CHYLOMICRONS

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

Mycophenolate oral suspension

CONAZOLANTIFUNGAL KETOE IN SOLUTION OR SUSPENSION FOR USE IN THE HUMAN EAR

Injectable Formulations

COMPOSITION AND METHODS FOR ACTIVATING CELLULAR SIGNALING GENES IN INNATE INFLAMMATORY PATHWAYS

ANTIBIOTIC THERAPY GUIDANCE BASED ON PROCALCITONIN IN PATIENTS WITH COMORBIDITIES

METHODS TO PREDICT THE EFFICACY OF NEOADJUVANT ANTI-PD-1 THERAPY IN RESECTABLE ORAL-CAVITY SQUAMOUS CELL CARCINOMA AND TARGET POST-SURGICAL RELAPSES

METHODS OF TREATING CANCERS HAVING A BIALLELIC LOSS OF FUNCTION OR GENE OVEREXPRESSION MUTATION

STAUFEN1 REGULATING AGENTS AND ASSOCIATED METHODS

LYSOSTAPHIN VARIANTS AND METHODS OF USE THEREOF

GENERATING CARDIAC PROGENITOR CELLS FROM PLURIPOTENT STEM CELLS USING ISOXAZOLE OR ISOXAZOLE LIKE COMPOUNDS

AGONISTIC CD40 ANTIBODIES AS IMMUNE STIMULATORY AGENTS

ANTI-ROR ANTIBODY CONSTRUCTS

METHODS FOR INHIBITING MYOSTATIN ACTIVATION BY ADMINISTERING ANTI-PRO/LATENT MYOSTATIN ANTIBODIES

INTERLEUKIN-2 MUTANT AND FUSION PROTEIN THEREOF

BIOMIMETIC PEPTIDE AND BIODEGRADABLE DELIVERY PLATFORM FOR THE TREATMENT OF ANGIOGENESIS- AND LYMPHANGIOGENESIS-DEPENDENT DISEASES

HALOGENATED PHENYLARSINE OXIDE COMPOUND AND APPLICATION THEREOF

NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER

CRYSTALLINE FORMS OF A TLR7/TLR8 INHIBITOR

MACROCYCLIC COMPOUNDS AND USES THEREOF

SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4

METABOLITES OF GLP1R AGONISTS

POTENT AND SELECTIVE INHIBITORS OF IRAK4

Compounds and Compositions for the Treatment of Cancer, Retinal Disorders, and Cardiomyopathies

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE

GRANZYME B DIRECTED IMAGING AND THERAPY

POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES

VACCINATION IN ELDERLY PATIENTS

HUMAN PAPILLOMAVIRUS VACCINES AND USES OF THE SAME

CHIMERIC VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTIGEN-SPECIFIC REDIRECTORS OF IMMUNE RESPONSES

METHOD OF TREATING CANCER WITH A CANCER THERAPY IN COMBINATION WITH ANOTHER THERAPEUTIC AGENT

TREATMENT SYSTEM FOR SYNERGISTICALLY INHIBITING A SPROUT ANGIOGENESIS

COMPOSITIONS AND METHODS FOR MODULATING GLYCEMIC RESPONSE

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES AND THYROID DISEASES

METHOD OF TREATING CANCER

OKRA-DERIVED ANTIVIRAL COMPOSITION AND USES THEREOF

MAGNESIUM/LITHIUM PREPARATIONS FOR NEUROPROTECTION AND NEUROTROPHIC BENEFITS

USE OF SODIUM THIOSULFATE (STS) WITH AND WITHOUT COFACTORS FOR THE TREATMENT OF INFLAMMATORY, NEURODEGENERATIVE AND NEUROPSYCHIATRIC CONDITIONS

COMPOSITION COMPRISING GLYCOSAMINOGLYCAN DERIVATIVE AND CHEMOKINE RECEPTOR ACTIVITY REGULATOR

METHOD OF TREATING HEPATITIS C VIRUS IN PATIENTS

MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING BONE RELATED DISEASES AND SYMPTOMS

NITRIC OXIDE RELEASING PROSTAMIDE AS NEUROPROTECTIVE AGENT

METHOD FOR TREATING CANCER

USE OF JAK1 INHIBITORS FOR THE TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOSUS AND LICHEN PLANUS (LP)

METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS

Novel Pyridine Compositions and their use in methods for preventing or treating diseases, disorders and conditions

METHODS OF TREATING ERYTHROPOIETIC PROTOPORPHYRIA, X-LINKED PROTOPORPHYRIA, OR CONGENITAL ERYTHROPOIETIC PORPHYRIA WITH A SOLID FORM OF BITOPERTIN

DOSING REGIMEN OF CAPSID INHIBITOR

USE OF A PHOSPHODIESTERASE 10 INHIBITOR FOR THE TREATMENT OF TOURETTE SYNDROME

ORAL BENDAMUSTINE FORMULATIONS

PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER

Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders

Treatment of mitochondrial diseases

Terpene Control in Scaleable Cannabinoids Medicinal Formulations

COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS RELATING TO CORONAVIRUS INFECTIONS

METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA

ENTHESIS HEALING

PROCESS FOR MAKING A SOLVENT-FREE NANODISPERSION FOR FAT-SOLUBLE VITAMINS AND NUTRACEUTICALS

ODONTOSTOMATOLOGICAL PREPARATION COMPRISING HYALURONIC ACID, ANTIBIOTICS AND GROWTH FACTORS

METHOD AND COMPOSITION FOR TREATING OBESITY

Mycophenolate oral suspension

HEMOSTATIC COMPOSITIONS AND RELATED METHODS

FORMULATIONS FOR TRANSDERMAL ADMINISTRATION OF ACTIVE AGENTS

TARGETED GENE THERAPY FOR DM-1 MYOTONIC DYSTROPHY

3D RECONSTITUTED BONE MARROW NICHE AND USES THEREOF

ANTI-CD40 ANTIBODY AND USE THEREOF

HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USE

COMPOSITION FOR TREATING OR PREVENTING IMMUNOLOGICAL ABNORMAL INFLAMMATORY DISEASES

De Novo Designed alpha(5) beta(1) Integrin selective minibinders

FUSION PROTEINS OF NATURAL HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN Fc COMPOSITIONS

Phenol Prodrugs

KRAS Modulating Compounds

AMIDE AND UREA-CONTAINING TRICYCLIC KRAS INHIBITORS

OXAZEPINE COMPOUNDS AND USES THEREOF IN THE TREATMENT OF CANCER

SMALL MOLECULE BTK DEGRADERS AND METHODS OF USE THEREOF

MODIFIED CARBAPENEM ANTIBIOTICS WITH IMPROVED ACTIVITY AGAINST KPC CARBAPENEMASE-PRODUCING ENTEROBACTERALES

CHEMICAL COMPOUNDS

Hydroxamic Acid Compound Having ENPP1 Inhibitory Activity and Use Thereof

BENZIMIDAZOLE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD

MULTI-TARGETED TYROSINE KINASE INHIBITORS EFFECTIVE IN ANTITUMOR USES

INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

QUATERNARY TRYPTAMINES AND THEIR THERAPEUTIC USES

Self-Assembling Nanoparticles Based On Amphiphilic Peptides for Drug Delivery Applications

BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF

NECTIN-4 ANTIBODIES AND CONJUGATES

EGFR PROTEOLYSIS TARGETING CHIMERIC MOLECULES AND ASSOCIATED METHODS OF USE

Methods for treating, ameliorating or preventing infections using drug and vaccination combination treatment

COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER

Pharmaceutical composition for treating or improving edema and blood stasis after open surgery

PERILESIONAL TREATMENT OF SKIN CONDITIONS

MITOCHONDRIAL AUGMENTATION THERAPY FOR MYELODYSPLASTIC SYNDROME

METHODS OF TREATING OVARIAN CONDITIONS AND DISEASES

NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION

Means and Methods to Regulate Gut Dysbiosis

INDUCERS OF SENESCENCE, IN COMBINATION WITH A SELECTIVE DEATH RECEPTOR 5 (DR5) AGONIST, FOR USE IN A METHOD OF TREATING CANCER

THERAPEUTIC CONSTRUCTS FOR CO-DELIVERY OF ANTI-CANCER AGENT(S) AND IMMUNE CHECKPOINT INHIBITOR(S)

PYRIMIDINEDIONE COMPOUNDS

COMPOSITION FOR TREATING, PREVENTING, OR AMELIORATING MELANOMA AND METHOD THEREOF

Compositions and Methods for Preventing or Improving Premature Skin Aging

COMPOSITIONS AND DOSAGE FORMS FOR TOPICAL AND TRANSDERMAL DELIVERY OF ACTIVES AND METHODS OF USE

ORGANONITRO AND SULFOXYALKYL ORGANONITRO COMPOUNDS FOR USE IN TREATING MEDICAL DISORDERS

METHODS FOR TREATING CORONAVIRUS INFECTION

BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM

METHODS OF ADJUVANT THERAPY

POLYMERIC MICELLE NANOPARTICLES FOR ON-DEMAND CELLULAR PACKAGING OF EXTRACELLULAR VESICLES

WATER SOLUBLE COMPOSITIONS AND METHODS OF MAKING THE SAME

Compositions Comprising Guaifenesin and Eriodictyol

EXTRAMAMMARY PAGET DISEASE BIOMARKERS AND USES THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF ANGIOPOIETIN-LIKE 3 (ANGPTL3) PROTEIN

ANTIBODIES AGAINST CLEAVED CDCP1 AND USES THEREOF

ANTIBODIES SPECIFIC TO HUMAN NECTIN4

MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF

METHODS OF USING INTERLEUKIN-2 AGENTS

Crystal Forms, Preparation Method And Application Of Aryl Phosphine Oxide Compound

KRAS G12D INHIBITORS AND USES THEREOF

PRMT5 INHIBITORS AND USES THEREOF

COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS

METHODS OF TREATMENT USING BCN057, BCN077 AND ANALOGS

THERAPEUTIC COMPOUNDS

NAMPT INHIBITORS AND USES THEREOF

HETEROCYCLIC GLP-1 AGONISTS

CRYSTALLINE FORM OF PYRROLE AMIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

PHENYL-SULFAMOYL-BENZOIC ACID DERIVATIVES AS ERAP1- MODULATORS

USE OF AN AGONIST OF FORMYL PEPTIDE RECEPTORS 1 AND 2 FOR TREATING OCULAR INFLAMMATORY DISEASES

BIFUNCTIONAL COMPOUND CAPABLE OF DEGRADING RECEPTOR TYROSINE KINASE AND APPLICATION THEREOF

IMMUNOGENIC TRIMERS

SARS-COV-2 IMMUNIZING COMPOSITIONS AND METHODS

UNGULATE-DERIVED POLYCLONAL IMMUNOGLOBULIN SPECIFIC FOR CORONAVIRUS PROTEIN AND USES THEREOF

VACCINE COMPOSITIONS COMPRISING BRUCELLA STRAINS AND METHODS THEREOF

MULTIPLEXED TP53 AND PAN-RAS mRNA CANCER VACCINES

METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1

METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1

METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1

PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING ULCER OR FISTULA IN INTESTINAL TRACT

COMPOSITIONS FOR PREVENTING AND/OR REDUCING VIRAL INFECTION

Inflammatory Respiratory Conditions and Treatments Thereof

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER USING BACTERIA

INTESTINAL MICROBIOTA AND GVHD

INTRACELLULAR DELIVERY OF BIOMOLECULES TO MODIFY IMMUNE RESPONSE

Subcutaneous injection method for pain treatment

Acellular Placental Therapies

Acellular Placental Therapies

METHODS FOR TREATING NEOPLASTIC DISEASES

COMPOSITIONS AND METHODS FOR ENHANCING STEM CELL SURVIVAL

TREATMENT OF SCHIZOPHRENIA WITH PDK1 INHIBITION BY COMBINING PDK1 INHIBITORS WITH LIPID REPLACEMENT THERAPY

USE OF H3K9me3 MODULATION FOR ENHANCING COGNITIVE FUNCTION

METHODS OF TREATING CANCER

CANCER TREATMENTS USING COMBINATIONS OF CDK AND ERK INHIBITORS

METHODS AND COMPOSITIONS FOR TREATING CANCER

METHODS AND COMPOSITIONS FOR TREATING CANCER

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME

MEDICINE FOR PREVENTION AND TREATMENT OF DISEASES LINKED TO ANTI-OBESITY ACTIVITY

NOVEL METHODS

SMALL MOLECULE INHIBITORS OF AUTOPHAGY AND HISTONE DEACTYLASES AND USES THEREOF

METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS

METHODS AND COMPOSITIONS FOR TREATING CANCER

AGENTS THAT TARGET TELOMERASE REVERSE TRANSCRIPTASE (TERT) FOR TREATING CANCER AND SENSITIZING CANCER CELLS TO GENOTOXIC THERAPY

METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS

DOSAGE REGIME WITH ESKETAMINE FOR TREATING MAJOR DEPRESSIVE DISORDER

METHODS FOR TREATING MUCOPOLYSACCHARIDOSIS

METHODS AND MATERIALS FOR KILLING HIV INFECTED CELLS

PHARMACEUTICAL COMPOSITION COMPRISING POLYSACCHARIDE

LIPIODOL FORMULATION FOR TRANSARTERIAL CHEMOIMMUNOEMBOLIZATION

METHOD OF DETECTING AND IDENTIFYING A MICROORGANISM

ANTI-TRYPTASE ANTIBODIES, COMPOSITIONS THEREOF, AND USES THEREOF

GENE SIGNATURES FOR MONITORING ACUTE REJECTION AND METHODS OF USING SAME

CD40L-SPECIFIC TN3-DERIVED SCAFFOLDS FOR USE IN THE TREATMENT AND PREVENTION OF RHEUMATOID ARTHRITIS

ANTI-ACVR2A ANTIBODIES AND USES THEREOF

GROWTH FACTOR ANTAGONISTS FOR ORGAN TRANSPLANT ALLOIMMUNITY AND ARTERIOSCLEROSIS

T Cell Receptors

SYNDECAN PEPTIDES

IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

SELECTIVE ISONITRILE INHIBITORS OF CYTOCHROME P450 SUBTYPES

COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR

KRAS INHIBITORS

AZA-TETRACYCLIC OXAZEPINE COMPOUNDS AND USES THEREOF

Macrocyclic Compounds Having ENT1 Inhibiting Activity

Antiviral Heterocyclic Compounds

SUBSTITUTED TRICYCLIC COMPOUNDS AS PARP INHIBITORS AND USE THEREOF

METHODS FOR TREATING CANCER

CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE

NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOF

ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

AURORA KINASE AND JANUS KINASE INHIBITORS FOR PREVENTION OF GRAFT VERSUS HOST DISEASE

SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF

Chimeric Antigen Receptor-Modified NK-92 Cells

STERILIZABLE PRE-FILLED PHARMACEUTICAL PACKAGES COMPRISING A LIQUID FORMULATION OF A VEGF-ANTAGONIST

ANTI-NECTIN-4 ANTIBODY, DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF

CHIMERIC FC-ALPHA RECEPTORS AND USES THEREOF

METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTICMICROBIAL THERAPEUTICS

INTERLEUKIN-12 SELF-REPLICATING RNA AND METHODS

COMBINATION OF A NURR1 AGONIST WITH AT LEAST ONE OF AN ALDOSTERONE ANTAGONIST, AN INSULIN MODULATOR AND A SULFONYLUREA

COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE

TISSUE CATALYZED GROWTH OF POLYMER AS EPITHELIAL LININGS FOR THERAPY

METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1

TCM LUNG TEA METHOD AND COMPOSITION

Aneurysm Treatment by Exosomes

METHODS AND COMPOSITIONS FOR ENHANCING THE CYTOTOXICITY OF GAMMA/DELTA-T CELLS

COMPOSITIONS FOR AND METHODS OF TREATING A SUBJECT HAVING INFLAMMATION

Delivery of Cellular Material and Other Material as a Dry Powder

TREATMENT OF DRUG RESISTANT PROLIFERATIVE DISEASES WITH TELOMERASE MEDIATED TELOMERE ALTERING COMPOUNDS

METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS

COMPRESSED TABLETS COMPRISING HMO

HETEROCYCLIC GLP-1 AGONISTS

USE OF ZINC PORPHYRIN AS AN ANTIMICROBIAL

ARYLQUINAZOLINES

USE OF QUINAZOLINONE COMPOUND FOR THE TREATMENT OF CANCER

SELECTIVE INHIBITORS OF ROCK2 FOR THE TREATMENT OF MUSCULAR DYSTROPHY

PHARMACEUTICAL COMPOSITIONS AND USE THEREOF

TREATMENT OF HFPEF IN POST-MENOPAUSAL WOMEN WITH AN SGC STIMULATOR

PHENYL-SULFAMOYL.BENZOYC ACIDS AS ERAP1 MODULATORS

Small Molecule Inhibitors of Formation of Neutrophil-Derived Extracellular Traps (NETosis) and Uses Thereof

ANTIPROLIFERATIVE COMPOUNDS AND BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 FOR COMBINED USE

Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2

COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS

METHODS AND AGENTS FOR MODULATING THE IMMUNE RESPONSE

TREATMENT OF RAYNAUD'S DISEASE

PHARMACEUTICAL COMPOSITION COMPRISING GPR40 AGONIST AND SGLT-2 INHIBITOR

TREATMENT OF PAIN AND VASOCONSTRICTION

METHODS OF TREATING ERYTHROPOIETIC PROTOPORPHYRIA, X-LINKED PROTOPORPHYRIA, OR CONGENITAL ERYTHROPOIETIC PORPHYRIA WITH GLYCINE TRANSPORT INHIBITORS

METHOD FOR TREATING INFLAMMATORY DISORDERS

COMPOSITIONS AND METHODS FOR TREATING TISSUE INJURY

PHARMACEUTICAL COMBINATIONS COMPRISING A KRAS G12C INHIBITOR AND USES THEREOF FOR THE TREATMENT OF CANCERS

Drug for Treating Prostatitis or Benign Prostatic Hyperplasia (BPH)

REGULATION OF MUTANT TERT BY BRAF V600E/MAP KINASE PATHWAY THROUGH FOS/GABP IN HUMAN CANCER

Hepatitis B Antiviral Agents

LASOFOXIFENE TREATMENT OF BREAST CANCER

METHOD OF TREATING MAJOR DEPRESSIVE DISORDER

Methods For Administering Weight Loss Medications

Synthetic progestogens and pharmaceutical compositions comprising the same

ORODISPERSIBLE POWDER COMPOSITION

TOPICAL PREPARATIONS OF DRUG DELIVERY FOR NASAL AND SINUS IRRIGATION

Reducing the Risk of Infection from Bacteria Present in Skin Pores During Surgery

SOLID SOLUBLE COMPOUND FOR APPLICATION AS A CARRIER OF ACTIVE AGENTS OR MULTIFUNCTIONAL COATING ON PLANT AND FRUIT STRUCTURES AND METHOD OF OBTAINMENT THEREOF

METHODS AND COMPOSITIONS FOR MODULATING GOBLET CELLS AND FOR MUCO-OBSTRUCTIVE DISEASES

RADIOGENOMIC SIGNATURES IN BLADDER CANCER PATIENTS AND USES THEREOF

TARGETED AND SLOW-RELEASE DRUG CONJUGATE COMPOSITION

EXTRA-HEPATIC DELIVERY IRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOLLOWING EXONS OF THE HUMAN DUCHENNE MUSCULAR DYSTROPHY GENE: 43, 46, 50-53

CELL THERAPEUTIC AGENT FOR CANCER TREATMENT AND COMBINATION THERAPY WITH SAME

NK CELLS EXHIBITING AN ADAPTIVE PHENOTYPE AND METHODS FOR PREPARING AND FOR USING

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

ANTIBODIES AGAINST YKL-40 AND USES THEREOF

HUMANIZED ANTIBODIES THAT BIND LGR5

USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT

METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY ADMINISTERING AN IL-4R ANTAGONIST

MULTISPECIFIC ANTIBODIES AND USES THEREOF

Safe and Effective Method of Treating Psoriasis with Anti-IL23 Specific Antibody

USE OF AN IL-18 ANTAGONIST FOR TREATING AND/OR PREVENTION OF ATOPIC DERMATITIS OR A RELATED CONDITION

ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES AND METHOD OF USE THEREOF

METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST

Antigen Binding Molecules Targeting SARS-CoV-2

BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE

STAPLED PEPTIDES AND METHODS THEREOF

Benzodiazepine derivatives as RSV inhibitors

INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE

INHIBITORS OF CANCER INVASION, ATTACHMENT, AND/OR METASTASIS

IMIDAZO[1,2-B]PYRIDAZINYL COMPOUNDS AND USES THEREOF

GLS1 INHIBITORS FOR TREATING DISEASE

BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS

COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION

SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

NOVEL KINASE MODULATORS

THERMODYNAMICALLY STABLE FORM OF SCO-101

6-HYDROXY-CANNABIDIOL-C4

TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY AND COMBINATIONS THEREOF

SHEAR-THINNING HYDROGELS AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS

COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MUSHROOM EXTRACT OR POWDER

MODIFIED COLLOIDAL PARTICLES FOR USE IN THE TREATMENT OF HAEMOPHILIA A

PEPTIDES AND METHODS OF TREATING DYSTROPHY-RELATED DISORDERS USING THE SAME

ALTERED VIRUS